317 related articles for article (PubMed ID: 33391469)
21. The potential of circulating exosomal RNA biomarkers in cancer.
Chu YL; Li H; Ng PLA; Kong ST; Zhang H; Lin Y; Tai WCS; Yu ACS; Yim AKY; Tsang HF; Cho WCS; Wong SCC
Expert Rev Mol Diagn; 2020 Jul; 20(7):665-678. PubMed ID: 32188269
[TBL] [Abstract][Full Text] [Related]
22. Identification of novel long non-coding RNAs deregulated in hepatocellular carcinoma using RNA-sequencing.
Esposti DD; Hernandez-Vargas H; Voegele C; Fernandez-Jimenez N; Forey N; Bancel B; Le Calvez-Kelm F; McKay J; Merle P; Herceg Z
Oncotarget; 2016 May; 7(22):31862-77. PubMed ID: 26887054
[TBL] [Abstract][Full Text] [Related]
23. Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma.
Wang Z; Gao P; Sun W; Rehman AU; Jiang J; Xu S; Xue C; Zhu C; Qin X
Front Endocrinol (Lausanne); 2023; 14():938102. PubMed ID: 36793272
[TBL] [Abstract][Full Text] [Related]
24. Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma.
Wang Y; Zhang C; Zhang P; Guo G; Jiang T; Zhao X; Jiang J; Huang X; Tong H; Tian Y
Cancer Med; 2018 May; 7(5):1670-1679. PubMed ID: 29573235
[TBL] [Abstract][Full Text] [Related]
25. Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma.
Welberry C; Macdonald I; McElveen J; Parsy-Kowalska C; Allen J; Healey G; Irving W; Murray A; Chapman C
PLoS One; 2020; 15(5):e0232247. PubMed ID: 32374744
[TBL] [Abstract][Full Text] [Related]
26. exRNAdisease: An extracellular RNA transcriptome atlas in human diseases.
Zhao L; Ning Q; Zheng G; Luo J; Dong D
Gene; 2022 Aug; 836():146662. PubMed ID: 35690280
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
28. Integrated analysis highlights multiple long non‑coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma.
Li CY; Zhang WW; Xiang JL; Wang XH; Wang JL; Li J
Oncol Rep; 2019 Dec; 42(6):2583-2599. PubMed ID: 31638253
[TBL] [Abstract][Full Text] [Related]
29. Circulating RNAs in prostate cancer patients.
Mugoni V; Ciani Y; Nardella C; Demichelis F
Cancer Lett; 2022 Jan; 524():57-69. PubMed ID: 34656688
[TBL] [Abstract][Full Text] [Related]
30. The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma.
Best J; Bilgi H; Heider D; Schotten C; Manka P; Bedreli S; Gorray M; Ertle J; van Grunsven LA; Dechêne A
Z Gastroenterol; 2016 Dec; 54(12):1296-1305. PubMed ID: 27936479
[No Abstract] [Full Text] [Related]
31. [Advances in the role of exosome-derived long non-coding RNAs in hepatocellular carcinoma].
Zhou C; Wang CJ
Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):77-81. PubMed ID: 30685932
[TBL] [Abstract][Full Text] [Related]
32. The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma.
Xu L; Zhang M; Zheng X; Yi P; Lan C; Xu M
J Cancer Res Clin Oncol; 2017 Jan; 143(1):17-27. PubMed ID: 27614453
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA.
Hlady RA; Zhao X; Pan X; Yang JD; Ahmed F; Antwi SO; Giama NH; Patel T; Roberts LR; Liu C; Robertson KD
Theranostics; 2019; 9(24):7239-7250. PubMed ID: 31695765
[TBL] [Abstract][Full Text] [Related]
34. N-glycan fingerprint predicts alpha-fetoprotein negative hepatocellular carcinoma: A large-scale multicenter study.
Huang C; Fang M; Feng H; Liu L; Li Y; Xu X; Wang H; Wang Y; Tong L; Zhou L; Gao C
Int J Cancer; 2021 Aug; 149(3):717-727. PubMed ID: 33729545
[TBL] [Abstract][Full Text] [Related]
35. TUG1 Is a Regulator of AFP and Serves as Prognostic Marker in Non-Hepatitis B Non-Hepatitis C Hepatocellular Carcinoma.
Lin YH; Wu MH; Huang YH; Yeh CT; Lin KH
Cells; 2020 Jan; 9(2):. PubMed ID: 31973032
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of extracellular signal-regulated kinase and YB-1 to enhance hepatocarcinogenesis.
Li D; Liu X; Zhou J; Hu J; Zhang D; Liu J; Qiao Y; Zhan Q
Hepatology; 2017 May; 65(5):1612-1627. PubMed ID: 28027578
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
[TBL] [Abstract][Full Text] [Related]
38. Identification of exosomal hsa-miR-483-5p as a potential biomarker for hepatocellular carcinoma via microRNA expression profiling of tumor-derived exosomes.
Lin J; Lin W; Bai Y; Liao Y; Lin Q; Chen L; Wu Y
Exp Cell Res; 2022 Aug; 417(2):113232. PubMed ID: 35659970
[TBL] [Abstract][Full Text] [Related]
39. Identifying novel transcript biomarkers for hepatocellular carcinoma (HCC) using RNA-Seq datasets and machine learning.
Gupta R; Kleinjans J; Caiment F
BMC Cancer; 2021 Aug; 21(1):962. PubMed ID: 34445986
[TBL] [Abstract][Full Text] [Related]
40. Circular noncoding RNA hsa_circ_0005986 as a prognostic biomarker for hepatocellular carcinoma.
Kim G; Han JR; Park SY; Tak WY; Kweon YO; Lee YR; Han YS; Park JG; Kang MK; Lee HW; Lee WK; Kim D; Jang SY; Hur K
Sci Rep; 2021 Jul; 11(1):14930. PubMed ID: 34294754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]